<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:158.5pt;left:32.8pt;line-height:9.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:9.8pt">Review Article</span></p>
<p style="top:177.2pt;left:32.8pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">The non-reconstructive treatment of complete ACL tear with</span></p>
<p style="top:194.5pt;left:32.8pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">biological enhancement in clinical and preclinical studies: A</span></p>
<p style="top:211.7pt;left:32.8pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">systematic review</span></p>
<p style="top:236.9pt;left:32.8pt;line-height:10.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">Yue Li</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">a</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Sai Cheun Fu</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">b</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> c</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Yau Chuk Cheuk</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">b</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> c</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Guanyang Song</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">a</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">, Hua Feng</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">a</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">,</span></p>
<p style="top:249.8pt;left:32.8pt;line-height:10.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">Shu-Hang Yung</span><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac">b</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.8pt;color:#0a7fac"> c</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:7.6pt">,</span></sup><sup><span style="font-family:AdvTT5843c571,serif;font-size:7.8pt;color:#0a7fac"> *</span></sup></p>
<p style="top:266.8pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">a</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Sports Medicine Service, Beijing Jishuitan Hospital, China</span></p>
<p style="top:275.3pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">b</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, China</span></p>
<p style="top:283.9pt;left:32.8pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">c</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, China</span></p>
<p style="top:316.1pt;left:32.8pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">a r t i c l e</span></p>
<p style="top:316.1pt;left:96.8pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">i n f o</span></p>
<p style="top:336.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Article history:</span></p>
<p style="top:345.3pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Received 18 December 2017</span></p>
<p style="top:353.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Received in revised form</span></p>
<p style="top:362.5pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">28 March 2018</span></p>
<p style="top:371.0pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Accepted 9 April 2018</span></p>
<p style="top:379.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Available online 18 May 2018</span></p>
<p style="top:316.1pt;left:197.2pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">a b s t r a c t</span></p>
<p style="top:337.1pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Introduction:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> There is still controversy regarding the bio-enhanced non-reconstructive ACL treatment.</span></p>
<p style="top:346.6pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Materials and methods:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> A search for articles in databases was performed in February 2017. The objective</span></p>
<p style="top:356.2pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">and subjective evaluations of clinical studies and biomechanical and histological data of preclinical</span></p>
<p style="top:365.8pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">studies were extracted.</span></p>
<p style="top:375.4pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Results:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> Eighteen articles were included for analysis. In clinical studies, although subjective scores were</span></p>
<p style="top:384.9pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">cantly improved, the rate of re-operation rate was high. In preclinical studies, bio-enhancing</span></p>
<p style="top:394.5pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">techniques demonstrated promotion of the healing of ACL.</span></p>
<p style="top:404.0pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Conclusions:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> The ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">cacy of biological enhancement cannot be validated in clinical studies. Preclinical</span></p>
<p style="top:413.6pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">studies showed improved biomechanical and healing potential.</span></p>
<p style="top:423.1pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOTb0c9bf5d,serif;font-size:7.3pt">&#xa9;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> 2018 Asia Paci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">c Knee, Arthroscopy and Sports Medicine Society. Published by Elsevier (Singapore) Pte</span></p>
<p style="top:432.7pt;left:197.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">Ltd. This is an open access article under the CC BY-NC-ND license (</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt;color:#0a7fac">http://creativecommons.org/licenses/</span></p>
<p style="top:442.2pt;left:501.7pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt;color:#0a7fac">by-nc-nd/4.0/</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">).</span></p>
<p style="top:478.6pt;left:32.8pt;line-height:7.2pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:7.2pt">Contents</span></p>
<p style="top:499.2pt;left:55.6pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10</span></p>
<p style="top:508.8pt;left:55.6pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11</span></p>
<p style="top:518.3pt;left:55.6pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11</span></p>
<p style="top:527.9pt;left:67.2pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Methodological quality assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11</span></p>
<p style="top:537.4pt;left:67.2pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Clinical studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11</span></p>
<p style="top:547.0pt;left:67.2pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Animal studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12</span></p>
<p style="top:556.6pt;left:77.7pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Collagen-platelet composite . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12</span></p>
<p style="top:566.1pt;left:77.7pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Suture repair and platelet-rich plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14</span></p>
<p style="top:575.7pt;left:77.7pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Suture repair and small intestinal submucosa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14</span></p>
<p style="top:585.3pt;left:77.7pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Extracellular matrix sheet and gel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14</span></p>
<p style="top:594.8pt;left:55.6pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14</span></p>
<p style="top:604.4pt;left:55.6pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15</span></p>
<p style="top:614.0pt;left:55.6pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">Conflicts of interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15</span></p>
<p style="top:623.5pt;left:55.4pt;line-height:7.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.2pt">References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15</span></p>
<p style="top:666.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Introduction</span></p>
<p style="top:687.3pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Currently, anterior cruciate ligament (ACL) reconstruction has</span></p>
<p style="top:697.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">been considered as the primary treatment of active young adult</span></p>
<p style="top:708.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients with ACL complete tear. However, there is still controversy</span></p>
<p style="top:692.6pt;left:37.9pt;line-height:6.5pt"><span style="font-family:AdvTT5843c571,serif;font-size:6.5pt">*</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Corresponding author. Room 74029, 5/F, Lui Che Woo Clinical Science Building,</span></p>
<p style="top:701.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Prince of Wales Hospital, Shatin, NT, Hong Kong, China.</span></p>
<p style="top:709.8pt;left:44.8pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">E-mail address:</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> patrickyung@cuhk.edu.hk</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> (S.-H. Yung).</span></p>
<img style="position:absolute;transform:matrix(1.3333334,0,0,1.3333334,666.6667,242.66669)" src="data:image/png;base64,
iVBORw0KGgoAAAANSUhEUgAAAB0AAAAdCAYAAABWk2cPAAAACXBIWXMAAA7EAAAO
xAGVKw4bAAAAl0lEQVR4nO3N2wqCUABE0fn/TwoOZhwMS+yiXSxJFEsMwyDB4DxM
fzFBtGE9b/AL4T/9valzjmoY3yPVMAwvqqF/9lRD9+iohvbeUg1Nc6Ma6mtNNZRV
STVcioJqOOc51ZCdMqphfzxQDckupRq2aUI1rDZrqiGKY6phES2phnkYUg02CKiG
mbVUw9T3qQbjeVTDxBiqfQCRO+Ni836ScAAAAABJRU5ErkJggg==">
<img style="position:absolute;transform:matrix(.31999464,0,-0,.31871564,-40.553995,17.426667)" src="data:image/jpeg;base64,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">
<p style="top:73.3pt;left:216.0pt;line-height:8.1pt"><span style="font-family:AdvPSA35D,serif;font-size:8.1pt">Contents lists available at</span><span style="font-family:AdvPSA35D,serif;font-size:8.1pt;color:#0a7fac"> ScienceDirect</span></p>
<p style="top:91.1pt;left:137.3pt;line-height:12.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:12.7pt">Asia-Paci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:12.7pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:12.7pt">c Journal of Sports Medicine, Arthroscopy,</span></p>
<p style="top:106.1pt;left:203.3pt;line-height:12.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:12.7pt">Rehabilitation and Technology</span></p>
<p style="top:128.5pt;left:202.2pt;line-height:8.1pt"><span style="font-family:AdvPSA35D,serif;font-size:8.1pt">journal homepage:</span><span style="font-family:AdvPSA35D,serif;font-size:8.1pt;color:#0a7fac"> www.ap-smart.com</span></p>
<img style="position:absolute;transform:matrix(.3199774,0,-0,.32004894,580.872,31.031983)" src="data:image/jpeg;base64,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">
<p style="top:728.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">https://doi.org/10.1016/j.asmart.2018.04.002</span></p>
<p style="top:736.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2214-6873/</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:6.5pt">&#xa9;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 2018 Asia Paci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">c Knee, Arthroscopy and Sports Medicine Society. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND</span></p>
<p style="top:745.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">license (</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">http://creativecommons.org/licenses/by-nc-nd/4.0/</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">).</span></p>
<p style="top:47.8pt;left:145.2pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#0a7fac">Asia-Paci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.4pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#0a7fac">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#0a7fac">16</span></p>


<p style="top:66.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">regarding</span></p>
<p style="top:66.1pt;left:87.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the</span></p>
<p style="top:66.1pt;left:108.2pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">best</span></p>
<p style="top:66.1pt;left:132.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatment</span></p>
<p style="top:66.1pt;left:178.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">algorithm</span></p>
<p style="top:66.1pt;left:224.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span></p>
<p style="top:66.1pt;left:240.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL</span></p>
<p style="top:66.1pt;left:262.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tear</span></p>
<p style="top:66.1pt;left:286.2pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in</span></p>
<p style="top:76.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adolescent,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvPS44A44B,serif;font-size:6.1pt;color:#0a7fac">e</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">4</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the middle-aged to elderly,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">5</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">6</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">skeletally immature</span></p>
<p style="top:87.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and low-demanding adult patients. In addition, tendon-bone</span></p>
<p style="top:97.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">healing,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">7</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">donor site morbidity,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">8</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">destruction of proprioception and</span></p>
<p style="top:108.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">vascularity, and non-anatomic placement were all potential prob-</span></p>
<p style="top:118.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lems for reconstructive treatment. Non-reconstructive approach</span></p>
<p style="top:128.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">primarily avoids the use of graft and extra trauma caused by drilling</span></p>
<p style="top:139.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bone tunnels, and probably preserves more proprioception with</span></p>
<p style="top:149.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">less destruction of ACL footprint.</span></p>
<p style="top:160.2pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Theoretically, torn ACL has healing potential.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">9</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">However, the</span></p>
<p style="top:170.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">outcome of non-reconstructive ACL treatment was not promising.</span></p>
<p style="top:181.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In a long-term follow-up study, Sanders et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">10</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">demonstrated 18-</span></p>
<p style="top:191.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">fold likelihood of secondary meniscal tears, 14-fold of arthritis,</span></p>
<p style="top:202.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and</span></p>
<p style="top:202.1pt;left:63.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">5-fold</span></p>
<p style="top:202.1pt;left:93.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span></p>
<p style="top:202.1pt;left:108.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">need</span></p>
<p style="top:202.1pt;left:133.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span></p>
<p style="top:202.1pt;left:148.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">total</span></p>
<p style="top:202.1pt;left:172.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">knee</span></p>
<p style="top:202.1pt;left:197.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">arthroplasty</span></p>
<p style="top:202.1pt;left:251.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with</span></p>
<p style="top:202.1pt;left:275.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">non-</span></p>
<p style="top:212.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reconstructive</span></p>
<p style="top:212.6pt;left:105.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatment</span></p>
<p style="top:212.6pt;left:152.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">comparing</span></p>
<p style="top:212.6pt;left:201.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with</span></p>
<p style="top:212.6pt;left:228.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACLR.</span></p>
<p style="top:212.6pt;left:258.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Similarly,</span></p>
<p style="top:223.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">discouraging outcome of ACL single repair was also reported by a</span></p>
<p style="top:233.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">recent systematic review.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">3</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">From the above discouraging results, it</span></p>
<p style="top:243.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">seems that the self-healing capacity of ACL is very low, biological</span></p>
<p style="top:254.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">enhancement of healing may be necessary to keep the advantages</span></p>
<p style="top:264.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of non-reconstructive surgery and ensure suf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient healing re-</span></p>
<p style="top:275.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">sponses and good clinical outcomes.</span></p>
<p style="top:285.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The biological enhancement technique in ACL reconstruction</span></p>
<p style="top:296.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">has been well discussed in a systematic review by Fu et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">11</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">They</span></p>
<p style="top:306.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">suggested that biological modulation is able to promote healing at</span></p>
<p style="top:317.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the tunnel-graft interface. But the healing of the intra-articular</span></p>
<p style="top:327.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">midsubstance</span></p>
<p style="top:327.6pt;left:102.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span></p>
<p style="top:327.6pt;left:116.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the</span></p>
<p style="top:327.6pt;left:136.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">graft</span></p>
<p style="top:327.6pt;left:161.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was</span></p>
<p style="top:327.6pt;left:183.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">another</span></p>
<p style="top:327.6pt;left:220.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">consideration.</span></p>
<p style="top:327.6pt;left:281.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We</span></p>
<p style="top:338.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">included clinical and extended to preclinical studies that may</span></p>
<p style="top:348.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">provide more advanced insight for the further ACL tear treatment.</span></p>
<p style="top:359.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In the literature,</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x201c;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Healing Response Technique</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x201d;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (HRT) and</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x201c;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Dy-</span></p>
<p style="top:369.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">namic Intraligamentous Stabilization</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x201d;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (DIS) are two mainly used</span></p>
<p style="top:379.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">techniques in clinical studies, while a variety of innovative tech-</span></p>
<p style="top:390.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">niques were also applied in animal studies. HRT was described as</span></p>
<p style="top:400.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">perforating cortical bone at the femoral origin and the rupture</span></p>
<p style="top:411.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">stump, while DIS is employing internal stabilizer to keep the un-</span></p>
<p style="top:421.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">stable knee in a posterior translation, combined with micro-</span></p>
<p style="top:432.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">fracturing and platelet-rich</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">brin induction at the rupture site to</span></p>
<p style="top:442.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">promote self-healing.</span></p>
<p style="top:453.2pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The purpose of the systematic review was to describe the clin-</span></p>
<p style="top:463.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ical outcome and results of animal studies on non-reconstructive</span></p>
<p style="top:474.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatment of complete anterior cruciate ligament (ACL) tear with</span></p>
<p style="top:484.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">biological enhancement.</span></p>
<p style="top:505.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Materials and methods</span></p>
<p style="top:526.4pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We searched the Medline, Scopus and Ovid database in January</span></p>
<p style="top:536.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">2018 to identify all clinical and preclinical studies about the treat-</span></p>
<p style="top:547.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ment of complete ACL tear with non-reconstructive biological</span></p>
<p style="top:557.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">enhancement techniques based on the following criteria: (ACL OR</span></p>
<p style="top:568.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">anterior cruciate ligament) AND (repair OR healing) NOT (recon-</span></p>
<p style="top:578.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">struct*). The references of all included studies and related reviews</span></p>
<p style="top:589.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were also checked. The inclusion criteria were (1) English original</span></p>
<p style="top:599.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">articles published from January 1, 2000 to January 20, 2018; (2)</span></p>
<p style="top:610.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical or animal in vivo studies; (3) complete ACL tear; (4) and</span></p>
<p style="top:620.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">healing of ACL was enhanced by the use of bone marrow stimula-</span></p>
<p style="top:631.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tion, mesenchymal stem cells, growth factors, biomaterials, drugs</span></p>
<p style="top:641.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">or biophysical intervention (biological enhancement). Articles were</span></p>
<p style="top:651.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">excluded if they (1) were reviews, meta-analyses, case reports, or</span></p>
<p style="top:662.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">technical notes; (2) had application of any type of graft; (3)</span></p>
<p style="top:672.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">included concomitant posterior cruciate ligament and posterolat-</span></p>
<p style="top:683.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">eral complex lesions and patellofemoral disorders. It should be</span></p>
<p style="top:693.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">noted that since the management for ACL partial tear is different</span></p>
<p style="top:704.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">from complete tear and the relevant articles of partial tear was too</span></p>
<p style="top:714.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">few to synthesize, articles about partial tear were also excluded. All</span></p>
<p style="top:725.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">included studies retrieved from the search engines were initially</span></p>
<p style="top:735.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">checked manually by 2 independent co-authors by reviewing titles,</span></p>
<p style="top:66.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">abstracts and full-text articles for</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal application of the inclusion</span></p>
<p style="top:76.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and exclusion criteria. Any discrepancies were discussed and</span></p>
<p style="top:87.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">overcome by consensus.</span></p>
<p style="top:97.5pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The full texts of the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ltered included articles were then obtained</span></p>
<p style="top:108.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for data extraction. Data from clinical studies were mainly publi-</span></p>
<p style="top:118.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cation years,</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst author, type of biological enhancement and</span></p>
<p style="top:128.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">combined surgery, sample size, patients&apos; demographic data, key</span></p>
<p style="top:139.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">objective and subjective outcome measures, and other major</span></p>
<p style="top:149.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings. Data from animal studies were mainly publication years,</span></p>
<p style="top:160.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst author, type of biological enhancement and combined surgery,</span></p>
<p style="top:170.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">animal model, sample size, grouping methods, time of sacri</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ce,</span></p>
<p style="top:181.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">histological or radiological results, laxity data, and biomechanical</span></p>
<p style="top:191.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">data.</span></p>
<p style="top:202.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Assessment of quality of clinical studies and animal studies was</span></p>
<p style="top:212.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">then performed by two experienced clinicians and two senior re-</span></p>
<p style="top:223.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">searchers, respectively. Clinical studies were assessed with meth-</span></p>
<p style="top:233.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">odological index for non-randomized studies (MINORS).</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">12</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Since</span></p>
<p style="top:243.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">there were four additional criteria for comparative study, the ideal</span></p>
<p style="top:254.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">score was 16 for non-comparative studies and 24 for comparative</span></p>
<p style="top:264.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies. Animal studies were assessed according to the criteria</span></p>
<p style="top:275.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adapted from the checklist of Hooijmans et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The average score</span></p>
<p style="top:285.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of the two reviewers were recorded as the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal score.</span></p>
<p style="top:306.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Results</span></p>
<p style="top:327.6pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The initial research resulted in 1023 articles. After the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ltered</span></p>
<p style="top:338.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">research, 508 articles were excluded for publication date, type and</span></p>
<p style="top:348.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">language. The review on titles was conducted on 515 articles. After</span></p>
<p style="top:359.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the exclusion of 380 irrelevant articles, 135 articles were available</span></p>
<p style="top:369.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for further screening. Twenty-two eligible articles were retrieved. It</span></p>
<p style="top:379.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">should be noted that the article written by Eggli et al., in 2015</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">14</span></sup></p>
<p style="top:390.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">included the same series as they published in 2016</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">15</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, so the</span></p>
<p style="top:400.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">earlier article was not included for analysis. So 18 articles were</span></p>
<p style="top:411.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nally included for analysis. Among them, seven articles were</span></p>
<p style="top:421.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical studies and 11 articles were animal studies. Of the 7 clinical</span></p>
<p style="top:432.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies, there were 5 level</span><span style="font-family:AdvTT2876772e+21,serif;font-size:8.1pt"> &#x2163;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> case-series studies,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">2</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">15</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">18</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 1 level</span><span style="font-family:AdvTT2876772e+21,serif;font-size:8.1pt"> &#x2162;</span></p>
<p style="top:442.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">retrospective case-control studies</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">19</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 1 level</span><span style="font-family:AdvTT2876772e+21,serif;font-size:8.1pt"> &#x2162;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> cohort study</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">20</span></sup></p>
<p style="top:453.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Fig. 1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">). There were three techniques discussed in all 7 articles,</span></p>
<p style="top:463.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">HRT in 3 studies, DIS repair in 3 studies and bridge-enhanced ACL</span></p>
<p style="top:474.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair. One of the level</span><span style="font-family:AdvTT2876772e+21,serif;font-size:8.1pt"> &#x2162;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> studies compared the outcome of DIS</span></p>
<p style="top:484.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair with and without additional collagen application.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">19</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The</span></p>
<p style="top:495.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">other one compared the HRT and conservative treatment.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">17</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Of the</span></p>
<p style="top:505.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">11 animal studies, six compared bio-enhanced ACL repair and su-</span></p>
<p style="top:515.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ture repair only,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">21</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">26</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> one compared bio-enhanced repair with</span></p>
<p style="top:526.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL reconstruction,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">27</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and compared the outcome of bio-enhanced</span></p>
<p style="top:536.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL repair with different</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">xation methods,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">28</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">platelet-rich plasma</span></p>
<p style="top:547.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(PRP) injection temperature,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">29</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concentration of PRP</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">30</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and time of</span></p>
<p style="top:557.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">delay.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">31</span></sup></p>
<p style="top:578.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Methodological quality assessment</span></p>
<p style="top:599.6pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">For clinical studies, there were 4 cases-series studies, 2 case-</span></p>
<p style="top:610.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">control and 1 cohort studies. The quality scores were listed in the</span></p>
<p style="top:620.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">last column of</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac"> Table 1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. According to MINORS scoring system,</span></p>
<p style="top:631.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">comparative studies was evaluated by 4 more items than case-</span></p>
<p style="top:641.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">series studies. For animal studies, eight of twelve studies scores</span></p>
<p style="top:651.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">5</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">8, while 4 studies scored lower than 5, and they were considered</span></p>
<p style="top:662.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">as low-quality studies. Good interobserver reliability was obtained</span></p>
<p style="top:672.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">between assessors (intraclass correlation coef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient, 0.882; animal</span></p>
<p style="top:683.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies, intraclass correlation coef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient, 0.807), and consensus on</span></p>
<p style="top:693.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">scoring was reached by discussion.</span></p>
<p style="top:714.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Clinical studies</span></p>
<p style="top:735.6pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In total, 193 knees (129 male, 64 female) were evaluated at a</span></p>
<p style="top:47.8pt;left:144.1pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">Y. Li et al. / Asia-Paci</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.4pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">16</span></p>
<p style="top:47.8pt;left:555.9pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">11</span></p>


<p style="top:527.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">minimum follow-up of 2 years. Of all 193 knees, 91 knees (47.2%)</span></p>
<p style="top:538.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were treated with HRT which is fundamentally microfracture at the</span></p>
<p style="top:548.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">femoral insertion site without suturing ACL,102 knees (52.8%) were</span></p>
<p style="top:559.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treated with DIS repair with biological enhancement technique,</span></p>
<p style="top:569.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 10 knees were treated with bridge-enhance ACL repair pro-</span></p>
<p style="top:579.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cedure (BEAR) (</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Table 1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">).</span></p>
<p style="top:590.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">All studies reported the Lysholm and Tegner score at the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal</span></p>
<p style="top:600.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">follow-up. For HRT studies, the median or mean Lysholm scores</span></p>
<p style="top:611.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ranged from 90 to 96 scores. The median or mean Tegner scores</span></p>
<p style="top:621.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ranged from 5 to 8.5 scores, and failure rate from 8.9% to 36%. For</span></p>
<p style="top:632.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">DIS studies, the median or mean Lysholm scores ranged from 97 to</span></p>
<p style="top:642.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">100 scores. The median or mean Tegner scores ranged from 5.1 to 6</span></p>
<p style="top:653.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">scores, and failure rate from 0% to 20%. The BEAR scaffold in Murray</span></p>
<p style="top:663.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">et al.&apos;s clinical study</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">is the only device that</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lls the gap between</span></p>
<p style="top:674.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the torn ligament ends to have current Investigational Device</span></p>
<p style="top:684.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Exemption approval from the Food and Drug Administration. At 3-</span></p>
<p style="top:695.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">month follow-up, no joint infections or signs of signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant</span></p>
<p style="top:705.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammation were observed. There were no differences between</span></p>
<p style="top:715.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">groups in effusion or pain, and no failures by Lachman examination</span></p>
<p style="top:726.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">criteria or MRI evaluation.</span></p>
<p style="top:527.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Animal studies</span></p>
<p style="top:548.5pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">There were 11 eligible animal studies included for quantitative</span></p>
<p style="top:559.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">synthesis (</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">Table 2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">). Among them, there were 8 studies on pigs, 1 on</span></p>
<p style="top:569.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">minipigs and 2 on goats. The biological enhancement was mainly</span></p>
<p style="top:579.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">focused on 4 techniques: bio-enhanced ACL repair with collagen-</span></p>
<p style="top:590.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">platelet composite (CPC) combined with bone marrow stimula-</span></p>
<p style="top:600.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tion or other biomaterials,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">27</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">suture repair enhanced by PRP, locking</span></p>
<p style="top:611.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">suture technique with small intestinal submucosa (SIS) and suture</span></p>
<p style="top:621.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair wrapped by extracellular matrix (ECM) bioscaffolds and</span></p>
<p style="top:632.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">injected with ECM hydrogel.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">25</span></sup></p>
<p style="top:662.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Collagen-platelet composite</span></p>
<p style="top:672.8pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In the 7 studies</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">27</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">31</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> focusing on the application of CPC.</span></p>
<p style="top:683.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Among them, three of four studies</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">27</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">28</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">that made direct com-</span></p>
<p style="top:693.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">parison between bio-enhanced repair and repair only favored the</span></p>
<p style="top:704.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bio-enhanced ACL repair. Vavken et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">27</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">proved that bio-enhanced</span></p>
<p style="top:714.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL repair produced similar anterior-posterior (AP) laxity at 30</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span></p>
<p style="top:725.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">60</span><span style="font-family:AdvTT5843c571,serif;font-size:8.1pt">&#xba;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 90</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, maximum load, maximum displacement and linear</span></p>
<p style="top:735.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">stiffness with ACLR in a skeletally immature, large animal model.</span></p>
<img style="position:absolute;transform:matrix(.3199686,0,-0,.31984426,-288.47868,-486.96269)" src="data:image/jpeg;base64,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">
<p style="top:483.5pt;left:150.2pt;line-height:6.4pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.4pt">Fig. 1.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt"> PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.4pt"> &#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">owchart.</span></p>
<p style="top:47.8pt;left:134.4pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">Y. Li et al. / Asia-Paci</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.4pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">16</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">12</span></p>


<p style="top:638.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Joshi et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">discovered the technique produced the CPC ligaments</span></p>
<p style="top:649.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a 76% greater yield at load, a 320% increase in linear stiffness, and a</span></p>
<p style="top:659.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">47% decrease in the displacement at yield comparing with suture</span></p>
<p style="top:670.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair only after 3 months of healing. Histologically, although the</span></p>
<p style="top:680.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">CPC group had a signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly higher proportion of fusiform cells at</span></p>
<p style="top:691.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the 3-month time point than suture only group, there were still</span></p>
<p style="top:701.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant difference in cellularity, cell shape, vascularity, and</span></p>
<p style="top:712.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">collagen organization from intact ligament. Murray et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">28</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">modi-</span></p>
<p style="top:722.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">xation to a bone-to-bone fashion and proved its</span></p>
<p style="top:732.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">enhancement of yield load and linear stiffness comparing with</span></p>
<p style="top:638.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bone-to-ligament</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">xation. However, the AP laxity of both tech-</span></p>
<p style="top:649.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">niques was still signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly greater than the intact knee.</span></p>
<p style="top:659.6pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">On the contrary, Kiapour</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">discovered that when treated with</span></p>
<p style="top:670.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">absorbable suture, females had a lower ACL linear stiffness, yield</span></p>
<p style="top:680.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">load, maximum load and AP stability at 30</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">than suture repair only.</span></p>
<p style="top:691.0pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The condition of CPC application was also discussed. Magarian</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">32</span></sup></p>
<p style="top:701.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reported that after a delay of 2 or 6 weeks between transection and</span></p>
<p style="top:712.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair, the yield load of at postoperative 15 weeks was decreased by</span></p>
<p style="top:722.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">40% and 60%, maximum load decreased 55% and 60%, linear stiff-</span></p>
<p style="top:732.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ness decreased 50% and 50%, and AP laxity was 40% and 10% higher,</span></p>
<p style="top:66.2pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 1</span></p>
<p style="top:74.8pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Summary of clinical studies.</span></p>
<p style="top:89.0pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study</span></p>
<p style="top:89.0pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study</span></p>
<p style="top:97.5pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">design</span></p>
<p style="top:89.0pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Patients</span></p>
<p style="top:97.5pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">included</span></p>
<p style="top:89.0pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">M:F</span></p>
<p style="top:89.0pt;left:190.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Average</span></p>
<p style="top:97.5pt;left:190.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">age, yr</span></p>
<p style="top:89.0pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Mean F/</span></p>
<p style="top:97.5pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">U, mo</span></p>
<p style="top:89.0pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Bio-enhancement</span></p>
<p style="top:97.5pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">techniques</span></p>
<p style="top:89.0pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Surgical</span></p>
<p style="top:97.5pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">procedure on ACL</span></p>
<p style="top:89.0pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rate of</span></p>
<p style="top:97.5pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">reoperation</span></p>
<p style="top:89.0pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Assessment of outcome</span></p>
<p style="top:89.0pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">MINORS</span></p>
<p style="top:110.7pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Steadman et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">2</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Case</span></p>
<p style="top:119.2pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">series</span></p>
<p style="top:110.7pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">13</span></p>
<p style="top:110.7pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9:4</span></p>
<p style="top:110.7pt;left:190.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">13</span></p>
<p style="top:110.7pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">69</span></p>
<p style="top:110.7pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Bone marrow</span></p>
<p style="top:119.2pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">stimulation</span></p>
<p style="top:110.7pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ACL perforation</span></p>
<p style="top:110.7pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">23.1%</span></p>
<p style="top:110.7pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Instrumented SSD: 5 (3</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10)mm</span></p>
<p style="top:119.2pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lysholm: 96, Tegner: 8.5</span></p>
<p style="top:110.7pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">11</span></p>
<p style="top:127.8pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Steadman</span></p>
<p style="top:136.4pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">16</span></sup></p>
<p style="top:127.8pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Case</span></p>
<p style="top:136.4pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">series</span></p>
<p style="top:127.8pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">48</span></p>
<p style="top:127.8pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">13:35 51</span></p>
<p style="top:127.8pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">91.2</span></p>
<p style="top:127.8pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Bone marrow</span></p>
<p style="top:136.4pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">stimulation</span></p>
<p style="top:127.8pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ACL perforation</span></p>
<p style="top:127.8pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">8.9%</span></p>
<p style="top:127.8pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">More than 90% lower than</span></p>
<p style="top:136.4pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lachman Grade 3</span></p>
<p style="top:144.9pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lysholm: 90, Tegner: 5</span></p>
<p style="top:127.8pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10</span></p>
<p style="top:153.5pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Wasmaier</span></p>
<p style="top:162.1pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">17</span></sup></p>
<p style="top:153.5pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Case</span></p>
<p style="top:162.1pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">series</span></p>
<p style="top:153.5pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">28</span></p>
<p style="top:153.5pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">20:10 30.5</span></p>
<p style="top:153.5pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">51.0</span></p>
<p style="top:153.5pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Bone marrow</span></p>
<p style="top:162.1pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">stimulation</span></p>
<p style="top:153.5pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ACL perforation</span></p>
<p style="top:153.5pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">36%</span></p>
<p style="top:153.5pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant higher anterior knee</span></p>
<p style="top:162.1pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">laxity</span></p>
<p style="top:170.7pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lysholm: 91.2, Tegner: 5.7</span></p>
<p style="top:153.5pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">16</span></p>
<p style="top:179.2pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Evangelopoulos</span></p>
<p style="top:187.8pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">19</span></sup></p>
<p style="top:179.2pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Case</span></p>
<p style="top:187.8pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">control</span></p>
<p style="top:179.2pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study: 23</span></p>
<p style="top:187.8pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Control: 33</span></p>
<p style="top:179.2pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">39:17 30</span></p>
<p style="top:179.2pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24</span></p>
<p style="top:179.2pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Collagen membrane DIS repair</span></p>
<p style="top:179.2pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">0%</span></p>
<p style="top:179.2pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study group vs control group</span></p>
<p style="top:187.8pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Instrumented SSD: 1.0 mm vs</span></p>
<p style="top:196.3pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1.0 mm</span></p>
<p style="top:204.9pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lysholm: 100 vs 95</span></p>
<p style="top:213.5pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Tegner: 6 vs 5</span></p>
<p style="top:179.2pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">19</span></p>
<p style="top:222.1pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Henle et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">18</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">a</span></sup></p>
<p style="top:222.1pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Case</span></p>
<p style="top:230.6pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">series</span></p>
<p style="top:222.1pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">69</span></p>
<p style="top:222.1pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">42:27 32.4</span></p>
<p style="top:222.1pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt">&#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24</span></p>
<p style="top:222.1pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Microfracturing</span></p>
<p style="top:222.1pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Sutures and DIS</span></p>
<p style="top:222.1pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2.9%</span></p>
<p style="top:222.1pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Instrumented SSD: 2.3 mm</span></p>
<p style="top:230.6pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lysholm: 97, Tegner: 5.1, IKDC:</span></p>
<p style="top:239.2pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">94.8</span></p>
<p style="top:222.1pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10</span></p>
<p style="top:247.8pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Eggli et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">15</span></sup></p>
<p style="top:247.8pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Case</span></p>
<p style="top:256.3pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">series</span></p>
<p style="top:247.8pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10</span></p>
<p style="top:247.8pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">8:2</span></p>
<p style="top:247.8pt;left:190.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">23.3</span></p>
<p style="top:247.8pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">60.3</span></p>
<p style="top:247.8pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Microfracturing</span></p>
<p style="top:247.8pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Sutures and DIS</span></p>
<p style="top:247.8pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">20%</span></p>
<p style="top:247.8pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Instrumented SSD: 2 mm</span></p>
<p style="top:256.3pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lysholm: 100, Tegner: 5.5, IKDC:</span></p>
<p style="top:264.9pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">98.9</span></p>
<p style="top:247.8pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10</span></p>
<p style="top:273.4pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Murray et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">20</span></sup></p>
<p style="top:273.4pt;left:100.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Cohort</span></p>
<p style="top:273.4pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study: 10</span></p>
<p style="top:282.0pt;left:130.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Control: 10</span></p>
<p style="top:273.4pt;left:170.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6:14</span></p>
<p style="top:273.4pt;left:190.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24</span></p>
<p style="top:273.4pt;left:225.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3</span></p>
<p style="top:273.4pt;left:258.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">BEAR scaffold</span></p>
<p style="top:273.4pt;left:322.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Suture</span></p>
<p style="top:273.4pt;left:381.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">0%</span></p>
<p style="top:273.4pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study group vs control group</span></p>
<p style="top:282.0pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lachman test: 8 grade A, 2 grade B</span></p>
<p style="top:290.6pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">vs 10 grade A</span></p>
<p style="top:299.2pt;left:424.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">IKDC: 54.3 vs 60.7</span></p>
<p style="top:273.4pt;left:531.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">20</span></p>
<p style="top:312.3pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">M, male; F, female; mo, months; yr, year; F/U, follow-up; d, day; mo, month NP, not provided; HRT, healing response technique; DIS, dynamic intraligamentary stabilization.</span></p>
<p style="top:319.5pt;left:48.4pt;line-height:4.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> There were 278 patients included in this study but only 69 patients were followed for a minimum of 2 years. The M:F, age at surgery, time from injury to surgery were</span></p>
<p style="top:329.5pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">obtained from the overall data.</span></p>
<p style="top:356.8pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 2</span></p>
<p style="top:365.4pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Summary of animal studies.</span></p>
<p style="top:379.6pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study</span></p>
<p style="top:379.6pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Animals Study design</span></p>
<p style="top:379.6pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">F/U</span></p>
<p style="top:379.6pt;left:256.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Outcome</span></p>
<p style="top:392.7pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Vavken</span></p>
<p style="top:401.3pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">14</span></sup></p>
<p style="top:392.7pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24 pigs</span></p>
<p style="top:392.7pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC vs ACLR vs control</span></p>
<p style="top:392.7pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">15 wk CPC and ACLR produced superior biomechanical outcomes to control group.</span></p>
<p style="top:409.8pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Kiapour</span></p>
<p style="top:418.4pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">18</span></sup></p>
<p style="top:409.8pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">17 pigs</span></p>
<p style="top:409.8pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC vs control</span></p>
<p style="top:409.8pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">15 wk CPC showed worse mechanical outcome than control group</span></p>
<p style="top:427.0pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Murray</span></p>
<p style="top:435.5pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">23</span></sup></p>
<p style="top:427.0pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">12 pigs</span></p>
<p style="top:427.0pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC with ligament</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">xation</span></p>
<p style="top:435.5pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">vs tibial</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">xation</span></p>
<p style="top:427.0pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">15 wk Tibial</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">xation signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cantly improved mechanical outcomes.</span></p>
<p style="top:444.1pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Joshi et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">19</span></sup></p>
<p style="top:444.1pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">27 pigs</span></p>
<p style="top:444.1pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC vs control</span></p>
<p style="top:444.1pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4 wk</span></p>
<p style="top:452.7pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6 wk</span></p>
<p style="top:461.3pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3 mo</span></p>
<p style="top:444.1pt;left:256.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC showed in improvements in mechanical and histological assessments at 3 months.</span></p>
<p style="top:469.8pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Murray</span></p>
<p style="top:478.4pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">20</span></sup></p>
<p style="top:469.8pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5 pigs</span></p>
<p style="top:469.8pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Hydrogel-PRP vs control</span></p>
<p style="top:469.8pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4 wk</span></p>
<p style="top:469.8pt;left:256.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Hydrogel-PRP showed improvements in mechanical assessments.</span></p>
<p style="top:486.9pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Magarian</span></p>
<p style="top:495.5pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">26</span></sup></p>
<p style="top:486.9pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">16 pigs</span></p>
<p style="top:486.9pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC immediate repair vs</span></p>
<p style="top:495.5pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">delay of 2wks vs 6wks</span></p>
<p style="top:486.9pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">15 wk Delay of 2wks and 6wks both showed inferior mechanical outcomes and laxity test results.</span></p>
<p style="top:504.1pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Nguyen</span></p>
<p style="top:512.6pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">21</span></sup></p>
<p style="top:504.1pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10 goats Locking suture technique with and</span></p>
<p style="top:512.6pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">without SIS vs intact control</span></p>
<p style="top:504.1pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">12 wk The cross-sectional area of two suture groups was 35% and 50% of the intact control, respectively.</span></p>
<p style="top:512.6pt;left:256.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Suture-SIS group showed mechanical improvement than the Suture group at 30</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:4.6pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:521.2pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Palmer</span></p>
<p style="top:529.8pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">24</span></sup></p>
<p style="top:521.2pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4 pigs</span></p>
<p style="top:521.2pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC repair at 28.9</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">32.4</span><span style="font-family:AdvP4C4E74,serif;font-size:4.6pt"> </span><sup><span style="font-family:AdvP4C4E74,serif;font-size:4.6pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">C</span></p>
<p style="top:521.2pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">14 wk The mechanical property and histological outcome were inversely correlated with injection</span></p>
<p style="top:529.8pt;left:256.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">temperature.</span></p>
<p style="top:538.4pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Fisher et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">16 goats ECM sheet and hydrogel vs control</span></p>
<p style="top:538.4pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">12 wk The cross-sectional area and mechanical outcomes of ECM study group were signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant better than</span></p>
<p style="top:546.9pt;left:256.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">control.</span></p>
<p style="top:555.5pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Murray</span></p>
<p style="top:564.1pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">1</span></sup></p>
<p style="top:555.5pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6 pigs</span></p>
<p style="top:555.5pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">PRP vs control</span></p>
<p style="top:555.5pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">14 wk No signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant mechanical improvement in PRP group</span></p>
<p style="top:572.6pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Mastrangelo</span></p>
<p style="top:581.2pt;left:56.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:4.7pt;color:#0a7fac">25</span></sup></p>
<p style="top:572.6pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">8</span></p>
<p style="top:581.2pt;left:90.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">minipigs</span></p>
<p style="top:572.6pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Two groups:</span></p>
<p style="top:581.2pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">CPC with PRP 5x vs 3x baseline of</span></p>
<p style="top:589.8pt;left:120.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">platelets</span></p>
<p style="top:572.6pt;left:235.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">13 wk 5x baseline concentration resulted in a decrease in histological outcome.</span></p>
<p style="top:602.9pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ACL, anterior cruciate ligament; CPC, collagen platelet composite; F/U, follow up; wk, week; mo, month; PRP, platelet-rich plasma; AP, anterior-posterior; SIS, small intestinal</span></p>
<p style="top:611.5pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">submucosa; ECM, extra-cellular matrix.</span></p>
<p style="top:47.8pt;left:144.1pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">Y. Li et al. / Asia-Paci</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.4pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">16</span></p>
<p style="top:47.8pt;left:555.6pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">13</span></p>


<p style="top:66.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">respectively. Mastrangelo</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">30</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduced the concentration of PRP</span></p>
<p style="top:76.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">within the CPC from 5 times of systemic baseline to 3 times. There</span></p>
<p style="top:87.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was no signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant deterioration in biomechanical properties or AP</span></p>
<p style="top:97.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">laxity at 30</span><span style="font-family:AdvTT5843c571,serif;font-size:8.1pt">&#xba;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 90</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, but signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant greater laxity at 60</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, and worse</span></p>
<p style="top:108.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">histological characteristics (cellular density, orientation, shape,</span></p>
<p style="top:118.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">collagen formation and maturity index). Palmer</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">29</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">conducted a</span></p>
<p style="top:128.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">research on the effect of application temperature of CPC on the</span></p>
<p style="top:139.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ligament. In the in vitro study, injection temperatures of over 30</span><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt"> </span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">C</span></p>
<p style="top:149.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">resulted in gels with 50% lower stiffness than those below 30</span><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt"> </span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">C. In</span></p>
<p style="top:160.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the in vivo study, CPCs injected at a higher temperature resulted in</span></p>
<p style="top:170.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">50% of the repair strength when the temperature increased from</span></p>
<p style="top:181.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">29</span><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt"> </span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">C to 32.5</span><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt"> </span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">C.</span></p>
<p style="top:202.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Suture repair and platelet-rich plasma</span></p>
<p style="top:212.6pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Two studies reported the results after PRP application. Murray</span></p>
<p style="top:223.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">et al.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac"> </span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">23</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">injected hydrogel-PRP to the repair site enhance the suture</span></p>
<p style="top:233.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair. In the comparison with suture only, the bio-enhanced repair</span></p>
<p style="top:243.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">acquired 164%, 123% and 110% increase for load at yield, maximum</span></p>
<p style="top:254.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">load and tangent modulus, respectively, although the above pa-</span></p>
<p style="top:264.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rameters were still inferior to intact knee. However, in another</span></p>
<p style="top:275.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study by Murray et al.,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">they concluded that PRP alone was not</span></p>
<p style="top:285.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">suf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient to enhance ACL suture repair in terms of AP laxity and</span></p>
<p style="top:296.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">biomechanical properties.</span></p>
<p style="top:317.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Suture repair and small intestinal submucosa</span></p>
<p style="top:327.6pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In the study by Nguyen et al.,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">24</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACLs were sutured with</span></p>
<p style="top:338.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">customized-Becker suture technique. Goats were divided into two</span></p>
<p style="top:348.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">groups, suture only group and suture</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> SIS group in which six small</span></p>
<p style="top:359.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pieces of SIS (2 mm*2 mm*200</span><span style="font-family:AdvP3F4C13,serif;font-size:8.7pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">m) were placed within the mid-</span></p>
<p style="top:369.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">substance of the injury site. After 12 weeks of healing, the AP</span></p>
<p style="top:379.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">laxity at 30</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, 60</span><span style="font-family:AdvTT5843c571,serif;font-size:8.1pt">&#xba;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 90</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly greater in both groups</span></p>
<p style="top:390.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">than control. Gross morphology showed that the healing ACL was</span></p>
<p style="top:400.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">continuous with collagenous tissue in both groups. The cross-</span></p>
<p style="top:411.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">sectional area of the Suture and the Suture</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> SIS group was 35%</span></p>
<p style="top:421.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and50% of the intact control, respectively.</span></p>
<p style="top:442.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">Extracellular matrix sheet and gel</span></p>
<p style="top:453.2pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In the research by Fisher et al.,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">25</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">sixteen skeletally mature ACL-</span></p>
<p style="top:463.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">transected goats were divided into two groups, the ECM-treated</span></p>
<p style="top:474.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">group in which an ECM sheet was wrapped around the injury site</span></p>
<p style="top:484.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and with an ECM hydrogel injected into the transected site and the</span></p>
<p style="top:495.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">suture repair group in which the ACL was repaired by suture only. It</span></p>
<p style="top:505.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">demonstrated that the AP laxity of the ECM treated group was</span></p>
<p style="top:515.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly greater than the sham control. Histologically, all ECM-</span></p>
<p style="top:526.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treated ACLs healed with continuous neo-tissue formation and no</span></p>
<p style="top:536.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">noticeable concavities while only a small amount of neo-tissue</span></p>
<p style="top:547.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">formation in the suture repair group. The cross-sectional area of</span></p>
<p style="top:557.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the ECM-treated group was similar to sham operated controls and</span></p>
<p style="top:568.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was 4.5 times those of suture repair group. Biomechanically, stiff-</span></p>
<p style="top:578.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ness and ultimate load for the ECM-treated reached 48% and 20% of</span></p>
<p style="top:589.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the sham control. They concluded that the application of an ECM</span></p>
<p style="top:599.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bio-scaffold and hydrogel was found to accelerate the healing of a</span></p>
<p style="top:610.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">transected ACL following suture repair but failed to fully restore the</span></p>
<p style="top:620.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">function of normal ACL.</span></p>
<p style="top:641.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Discussion</span></p>
<p style="top:662.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The most important</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nding of the systematic review was (1)</span></p>
<p style="top:672.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">improved biomechanical and healing potential in bio-enhanced</span></p>
<p style="top:683.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL non-reconstructive treatment, (2) the satisfactory subjective</span></p>
<p style="top:693.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">outcome but an unacceptable high rate of re-instability and reop-</span></p>
<p style="top:704.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">eration, especially for some studies with HRT, although the validity</span></p>
<p style="top:714.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings were limited by low level of evidence.</span></p>
<p style="top:725.1pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In a systematic review of primary ACL repair, 20%</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">64% of patients</span></p>
<p style="top:735.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">underwent revision for re-instability.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">3</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">33</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In a 32-year follow-up</span></p>
<p style="top:66.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">study by Taylor et al.,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">34</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">28% of patients ultimately underwent an</span></p>
<p style="top:76.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">additional procedure for persistent symptomatic instability. Simi-</span></p>
<p style="top:87.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">larly, in the study by Strand et al.,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">35</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">at a 15</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">23-year follow-up, the</span></p>
<p style="top:97.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rate of instability was as high as 43%. Since the discouraging clinical</span></p>
<p style="top:108.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">outcome of ACL single repair,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">3</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">35</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACLR has become a popular treat-</span></p>
<p style="top:118.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ment of ACL rupture. However, comparing with non-reconstructive</span></p>
<p style="top:128.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatment, ACLR was not advantageous in skeletally immature,</span></p>
<p style="top:139.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adolescent,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">36</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">elder and non-active patients. In addition, the bone-</span></p>
<p style="top:149.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tendon healing,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">7</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">donor site morbidity,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">8</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">non-anatomic placement</span></p>
<p style="top:160.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">were also potential problems. If ACL repair can be successfully ach-</span></p>
<p style="top:170.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ieved, several advantages can be further provided, including the</span></p>
<p style="top:181.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">preservation of natural anatomy (femoral and tibial insertion sites</span></p>
<p style="top:191.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and multi-bundle nature), proprioception, and vascularity.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">37</span></sup></p>
<p style="top:202.1pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Unfortunately,</span></p>
<p style="top:202.1pt;left:374.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">unlike</span></p>
<p style="top:202.1pt;left:405.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">extra-articular</span></p>
<p style="top:202.1pt;left:466.2pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ligament</span></p>
<p style="top:202.1pt;left:506.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">like</span></p>
<p style="top:202.1pt;left:527.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">medial</span></p>
<p style="top:212.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">collateral ligament (MCL) which can successfully heal within blood</span></p>
<p style="top:223.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clot formation, the healing potential of ACL was compromised by</span></p>
<p style="top:233.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the abundance of plasmin in synovial</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uid which is an ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient</span></p>
<p style="top:243.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cleaver of</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">brin clot.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">38</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In addition to the hostile environment, ACL</span></p>
<p style="top:254.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">healing can also be compromised by biological factors such as cell</span></p>
<p style="top:264.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ciencies and alterations in cellular metabolism.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">14</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Given the</span></p>
<p style="top:275.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">poor healing capability of nature ACL, several biological enhance-</span></p>
<p style="top:285.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ment techniques for ACL healing have been proposed. So the goal of</span></p>
<p style="top:296.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">this systematic review was to synthesize the results of preclinical</span></p>
<p style="top:306.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and clinical studies respectively.</span></p>
<p style="top:317.2pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">All included animal studies were comparative studies. Of the 11</span></p>
<p style="top:327.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">animal studies, six compared bio-enhance ACL repair and suture</span></p>
<p style="top:338.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair only</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">21</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#0a7fac">25</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">28</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and one compared bio-enhanced repair with</span></p>
<p style="top:348.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL reconstruction. The results were still controversial. Two studies</span></p>
<p style="top:359.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reported discouraging results. Murray et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">found that PRP only</span></p>
<p style="top:369.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was not suf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient to enhance ACL healing. Kiapour et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">21</span></sup></p>
<p style="top:379.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">demonstrated inferior linear stiffness, ACL yield, maximum load,</span></p>
<p style="top:390.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and AP stability in female subjects with bio-enhanced repair than</span></p>
<p style="top:400.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">non-absorbable suture repair. However, the other four studies</span></p>
<p style="top:411.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">support that bio-enhancement technique did improve at least some</span></p>
<p style="top:421.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of the biomechanical or laxity properties. In a comparison with ACL</span></p>
<p style="top:432.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reconstruction, Vavken et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">27</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">showed that bio-enhanced ACL</span></p>
<p style="top:442.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">repair produced similar biomechanical results with ACL recon-</span></p>
<p style="top:453.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">struction in a skeletally immature porcine model. If we categorized</span></p>
<p style="top:463.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the studies into different approaches of enhancement, the CPC was</span></p>
<p style="top:474.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">most discussed and favored by most studies.</span></p>
<p style="top:484.5pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In terms of clinical studies, the rates of re-instability were 8.9%,</span></p>
<p style="top:495.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">23.1% and 36% in HRT studies, and 0%, 4.0% and 20% in DIS studies.</span></p>
<p style="top:505.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In terms of the re-operation rates, for HRT they were 8.9%, 23.1%</span></p>
<p style="top:515.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and 36%, while for DIS, they were 0%, 2.9% and 10%. It should be</span></p>
<p style="top:526.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">noted that, Steadman et al. reported the rate of 8.9% in an older and</span></p>
<p style="top:536.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">less active population (mean age: 51,</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal Tegner score: 5) than</span></p>
<p style="top:547.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Wasmaier et al.&apos;s cases (mean age: 31,</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal Tegner score: 5.7)</span></p>
<p style="top:557.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">whose re-operation rate was 36%. It seems that the DIS technique</span></p>
<p style="top:568.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">acquired relatively lower rate of re-instability and re-operation.</span></p>
<p style="top:578.7pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">According to literature, there are two main factors that in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uence</span></p>
<p style="top:589.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the wound healing, mechanical and biological environment.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">39</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In</span></p>
<p style="top:599.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">terms of the mechanical environment, the major difference be-</span></p>
<p style="top:610.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tween these two techniques was the structural continuity provided</span></p>
<p style="top:620.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">by intraligamentous stabilizer. DIS acted as an internal brace that</span></p>
<p style="top:631.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">provided torn ACL a stable mechanical environment for healing.</span></p>
<p style="top:641.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Although patients were locked in full extension with weight-</span></p>
<p style="top:651.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bearing for a total of 6 weeks and the ACL stump was held by</span></p>
<p style="top:662.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">marrow clots, the anterior tibial translation and micro-movement</span></p>
<p style="top:672.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in synovial</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uid might be inevitable.</span></p>
<p style="top:683.3pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">On the other hand, in terms of biological environment, in</span></p>
<p style="top:693.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">addition to microfracture, Eggli et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">15</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">also introduced leukocyte-</span></p>
<p style="top:704.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and platelet-rich</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">brin, and Evangelopoulos et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">19</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">applied</span></p>
<p style="top:714.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">collagen scaffold with DIS technique which could also be a reason of</span></p>
<p style="top:725.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">better outcome. The only study comparing ACL repair and ACLR was</span></p>
<p style="top:735.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">an early feasibility cohort study which was only followed for 3</span></p>
<p style="top:47.8pt;left:134.4pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">Y. Li et al. / Asia-Paci</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.4pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">16</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">14</span></p>


<p style="top:66.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">months.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">40</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The percent recovery of hamstring strength was greater</span></p>
<p style="top:76.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">at 3 months for the bio-enhanced group. No signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant difference</span></p>
<p style="top:87.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was detected in terms of adverse events, objective and subjective</span></p>
<p style="top:97.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">assessments and MRI (magnetic resonance imaging)</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings.</span></p>
<p style="top:108.0pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The only study that had been translated from preclinical to</span></p>
<p style="top:118.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical application was performed by Murray et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The effec-</span></p>
<p style="top:128.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tiveness of BEAR scaffold which was the only device that</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lls the</span></p>
<p style="top:139.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">gap between the torn ligament ends to have current Investigational</span></p>
<p style="top:149.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Device Exemption approval from the Food and Drug Administration</span></p>
<p style="top:160.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">has been proved by some of the preclinical studies that included in</span></p>
<p style="top:170.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">our review.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">26</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt">,</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">41</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In Murray et al.&apos;s early pilot clinical study,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">no</span></p>
<p style="top:181.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant adverse event or no difference in terms of effusion or</span></p>
<p style="top:191.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pain or objective evaluations were observed in the 10 patients</span></p>
<p style="top:202.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treated with BEAR procedure, although the follow-up was only 3</span></p>
<p style="top:212.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">month. Providing ACL a stable mechanical environment for healing</span></p>
<p style="top:223.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and an enhanced biological environment, and veri</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed by preclin-</span></p>
<p style="top:233.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ical studies, the long-term validity of BEAR procedure is promising.</span></p>
<p style="top:243.9pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">This study is mainly focused on ACL complete tear, however, a</span></p>
<p style="top:254.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">glimpse at the results of biological enhancement of partial tear</span></p>
<p style="top:264.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">healing may be inspiring. Although the evidence was limited, the</span></p>
<p style="top:275.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">outcome of biological enhancement in the treatment of ACL partial</span></p>
<p style="top:285.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tear seemed promising. Gobbi et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">42</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treated incomplete proximal</span></p>
<p style="top:296.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ACL tears with single repair and bone marrow stimulation. At a</span></p>
<p style="top:306.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mean of 25.3 months (range, 17</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">38 months) follow-up, the SSD</span></p>
<p style="top:317.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduced from 3.5 mm to 1.3 mm. Tegner, Marx and Noyes score</span></p>
<p style="top:327.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly improved and restored to a similar level as pre-injury.</span></p>
<p style="top:338.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Seijas et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">43</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">applied PRGF-Endoret in the remaining intact bundle</span></p>
<p style="top:348.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for football players. Fourteen of 19 patients returned to their pre-</span></p>
<p style="top:359.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">injury sports level 9 or 10 at 2-year follow-up. Murray et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">23</span></sup></p>
<p style="top:369.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">demonstrated signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant effects on the composition of tissue</span></p>
<p style="top:379.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lling the wound, increasing the presence of some cytokines to a</span></p>
<p style="top:390.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">similar level of that observed in the extra-articular ligament after</span></p>
<p style="top:400.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the application of collagen-PRP hydrogel on an ACL central-wound</span></p>
<p style="top:411.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">model. It should be noted that although the results seems prom-</span></p>
<p style="top:421.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ising, partial tear of the ACL needs more extensive work and dis-</span></p>
<p style="top:432.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cussion in near future with more evidence.</span></p>
<p style="top:442.7pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The preservation of proprioception was considered a main</span></p>
<p style="top:453.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">advantage of ACL repair. Henle et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">18</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">attributed their excellent</span></p>
<p style="top:463.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">clinical outcome to the preservation of proprioception. However,</span></p>
<p style="top:474.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">none of the 7 included clinical studies or studies on partial tear</span></p>
<p style="top:484.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">conducted any assessment on proprioception. Although it&apos;s not the</span></p>
<p style="top:495.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">same grade of preservation, remnant preserving in ACLR might also</span></p>
<p style="top:505.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">provide some information. In a study by Hong et al.,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">44</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the passive</span></p>
<p style="top:515.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">angle reproduction test result at 15</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was 3.6</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt">&#xb1;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 1.8</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in the remnant</span></p>
<p style="top:526.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">preserving group and 3.9</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt">&#xb1;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 2.2</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in the standard ACLR group</span></p>
<p style="top:536.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.739). In contrast, in another study,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">45</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal accuracy of</span></p>
<p style="top:547.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">joint position sense of remnant preserving group was signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cantly</span></p>
<p style="top:557.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">better than standard ACLR (0.7</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> &#xb1;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.7</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">vs. 1.7</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> &#xb1;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 1.2</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:6.1pt">&#xfffd;</span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, p</span><span style="font-family:AdvOTb0c9bf5d,serif;font-size:8.1pt"> &lt;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 0.05).</span></p>
<p style="top:568.2pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The timing of ACL repairing was also discussed. Magarian et al.</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">31</span></sup></p>
<p style="top:578.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">compared the biomechanical properties of ACL repair at time zero,</span></p>
<p style="top:589.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a delay of 2 weeks and 6 weeks. It demonstrated that the yield load</span></p>
<p style="top:599.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">decreased by 40% and 60%, maximum load by 55% and 60%, and</span></p>
<p style="top:610.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">linear stiffness by 50% and 50% in the group of 2-week and 6-week</span></p>
<p style="top:620.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">delay, respectively. AP laxity was 40% higher after 2-week delay and</span></p>
<p style="top:631.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">10% higher after 6-week delay. In the present review of clinical</span></p>
<p style="top:641.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies, surgeries were performed within a mean of 18 days from</span></p>
<p style="top:651.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">initial injury. And all animal studies performed repair at time zero.</span></p>
<p style="top:662.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">So it seemed that the ruptured ACL should be repaired in acute</span></p>
<p style="top:672.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">phase.</span></p>
<p style="top:683.3pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">There were some limitations in the present study. First, we</span></p>
<p style="top:693.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">classi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed marrow stimulation as a bio-enhancement approach, but</span></p>
<p style="top:704.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the component of blood clot was different from traditional blood-</span></p>
<p style="top:714.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">derived bio-enhancement approach, like PRP. PRP is a concen-</span></p>
<p style="top:725.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">trated source of platelet and contains a large amount of native</span></p>
<p style="top:735.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">growth factors without erythrocytes that would be expected to</span></p>
<p style="top:66.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">undergo necrosis shortly after clot formation,</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.1pt;color:#0a7fac">46</span></sup><sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> </span></sup><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">while blood clot</span></p>
<p style="top:76.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">contains all components of full blood without concentration. Sec-</span></p>
<p style="top:87.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ond, there is a chance that we may miss some relevant study</span></p>
<p style="top:97.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">because of publication bias and some gray literature. Third, only 2</span></p>
<p style="top:108.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of 6 clinical studies were retrospective comparative studies and the</span></p>
<p style="top:118.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">level of evidence was not higher than three. Fourth, the bio-</span></p>
<p style="top:128.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">enhancement technique was not homogeneous for both clinical</span></p>
<p style="top:139.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and animal studies, although we illustrated the results according to</span></p>
<p style="top:149.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">different techniques. Fifth, some animal studies of the bio-</span></p>
<p style="top:160.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">enhanced ACL repair and suture repair are from the same</span></p>
<p style="top:170.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">research group, so the results may be biased. Last, the results of</span></p>
<p style="top:181.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">animal studies cannot be directly interpreted to human outcomes.</span></p>
<p style="top:204.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Conclusion</span></p>
<p style="top:225.5pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy of biological enhancement cannot be validated</span></p>
<p style="top:235.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">because of the low level of evidence of included studies. Animal</span></p>
<p style="top:246.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">studies showed improved biomechanical and healing potential in</span></p>
<p style="top:256.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">bio-enhanced ACL non-reconstructive treatment.</span></p>
<p style="top:280.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Con</span><span style="font-family:AdvOTb83ee1dd.B+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">icts of interest</span></p>
<p style="top:301.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The authors have declared no</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nancial con</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">icts of interest with</span></p>
<p style="top:311.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">respect to their authorship and publication of this work.</span></p>
<p style="top:335.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">References</span></p>
<p style="top:354.3pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Murray MM, Palmer M, Abreu E, Spindler KP, Zurakowski D, Fleming BC.</span></p>
<p style="top:362.3pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Platelet-rich plasma alone is not suf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cient to enhance suture repair of the ACL</span></p>
<p style="top:370.3pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">in skeletally immature animals: an in vivo study.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2009;27:</span></p>
<p style="top:378.2pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">639</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">645</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:386.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Steadman JR, Cameron-Donaldson ML, Briggs KK, Rodkey WG. A minimally</span></p>
<p style="top:394.1pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">invasive technique (</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt;color:#0a7fac">&#x201c;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">healing response</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt;color:#0a7fac">&#x201d;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">) to treat proximal ACL injuries in</span></p>
<p style="top:402.1pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">skeletally immature athletes.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Knee Surg</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2006;19:8</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">13</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:410.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Taylor SA, Khair MM, Roberts TR, DiFelice GS. Primary repair of the anterior</span></p>
<p style="top:418.1pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cruciate ligament: a systematic review.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Arthroscopy</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2015;31:2233</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2247</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:426.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Webster KE, Feller JA. Exploring the high Reinjury rate in younger patients</span></p>
<p style="top:434.0pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">undergoing anterior cruciate ligament reconstruction.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:442.0pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2016;44:2827</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2832</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:450.0pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Struewer J, Ziring E, Oberkircher L, Schuttler KF, Efe T. Isolated anterior cruciate</span></p>
<p style="top:457.9pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ligament reconstruction in patients aged</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">fty years: comparison of hamstring</span></p>
<p style="top:465.9pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">graft versus bone-patellar tendon-bone graft.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Int Orthop</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2013;37:809</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">817</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:473.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Barber FA, Aziz-Jacobo J, Oro FB. Anterior cruciate ligament reconstruction</span></p>
<p style="top:481.8pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">using</span></p>
<p style="top:481.8pt;left:345.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">patellar</span></p>
<p style="top:481.8pt;left:374.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">tendon</span></p>
<p style="top:481.8pt;left:401.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">allograft:</span></p>
<p style="top:481.8pt;left:433.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">an</span></p>
<p style="top:481.8pt;left:446.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">age-dependent</span></p>
<p style="top:481.8pt;left:497.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">outcome</span></p>
<p style="top:481.8pt;left:529.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">evaluation.</span></p>
<p style="top:489.8pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Arthroscopy</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2010;26:488</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">493</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:497.8pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">7.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Kanazawa T, Soejima T, Noguchi K, et al. Tendon-to-bone healing using</span></p>
<p style="top:505.8pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">autologous bone marrow-derived mesenchymal stem cells in ACL reconstruc-</span></p>
<p style="top:513.7pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">tion without a tibial bone tunnel-A histological study.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Muscles Ligaments Ten-</span></p>
<p style="top:521.7pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">dons J.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> 2014;4:201</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">206</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:529.6pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">8.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Seijas R, Rius M, Ares O, Garcia-Balletbo M, Serra I, Cugat R. Healing of donor</span></p>
<p style="top:537.6pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in</span></p>
<p style="top:545.6pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">growth factors: a randomized clinical trial.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Knee Surg Sports Traumatol Arthrosc</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:553.6pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2015;23:991</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">997</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:561.6pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Seitz H, Menth-Chiari WA, Lang S, Nau T. Histological evaluation of the healing</span></p>
<p style="top:569.5pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">potential of the anterior cruciate ligament by means of augmented and non-</span></p>
<p style="top:577.5pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">augmented repair: an in vivo animal study.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Knee Surg Sports Traumatol</span></p>
<p style="top:585.5pt;left:324.2pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Arthrosc</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2008;16:1087</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1093</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:593.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Sanders TL, Pareek A, Kremers HM, et al. Long-term follow-up of isolated ACL</span></p>
<p style="top:601.4pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">tears treated without ligament reconstruction.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Knee Surg Sports Traumatol</span></p>
<p style="top:609.3pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Arthrosc</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2017 Feb;25(2):493</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">500</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:617.3pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">11.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Fu SC, Cheuk YC, Yung SH, Rolf CG, Chan KM. Systematic review of biological</span></p>
<p style="top:625.3pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">modulation of healing in anterior cruciate ligament reconstruction.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Orthop J</span></p>
<p style="top:633.3pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Sports Med.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> 2014;2, 2325967114526687</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:641.3pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">12.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological</span></p>
<p style="top:649.2pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">index for non-randomized studies (minors): development and validation of a</span></p>
<p style="top:657.2pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">new instrument.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> ANZ J Surg</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2003;73:712</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">716</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:665.1pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">13.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. A gold standard publication</span></p>
<p style="top:673.1pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">checklist to improve the quality of animal studies, to fully integrate the Three</span></p>
<p style="top:681.1pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Rs, and to make systematic reviews more feasible.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Altern Lab Anim.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> 2010;38:</span></p>
<p style="top:689.1pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">167</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">182</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:697.1pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">14.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Eggli S, Kohlhof H, Zumstein M, et al. Dynamic intraligamentary stabilization:</span></p>
<p style="top:705.0pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">novel technique for preserving the ruptured ACL.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Knee Surg Sports Traumatol</span></p>
<p style="top:713.0pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Arthrosc</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2015;23:1215</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1221</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:720.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">15.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Eggli S, Roder C, Perler G, Henle P. Five year results of the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">rst ten ACL patients</span></p>
<p style="top:728.9pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">treated with dynamic intraligamentary stabilisation.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> BMC Muscoskel Disord</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:736.9pt;left:324.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2016;17:105</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:47.8pt;left:144.1pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">Y. Li et al. / Asia-Paci</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.4pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">16</span></p>
<p style="top:47.8pt;left:555.6pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">15</span></p>


<p style="top:66.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">16.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Steadman JR, Matheny LM, Briggs KK, Rodkey WG, Carreira DS. Outcomes</span></p>
<p style="top:74.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">following healing response in older, active patients: a primary anterior cruciate</span></p>
<p style="top:82.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ligament repair technique.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Knee Surg</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2012;25:255</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">260</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:90.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">17.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Wasmaier J, Kubik-Huch R, P</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">rrmann C, Grehn H, Bieg C, Eid K. Proximal</span></p>
<p style="top:98.1pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">anterior cruciate ligament tears: the healing response technique versus con-</span></p>
<p style="top:106.1pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">servative treatment.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Knee Surg</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2013;26:263</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">271</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:114.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">18.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Henle P, Roder C, Perler G, Heitkemper S, Eggli S. Dynamic Intraligamentary</span></p>
<p style="top:122.0pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Stabilization (DIS) for treatment of acute anterior cruciate ligament ruptures:</span></p>
<p style="top:130.0pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">case series experience of the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">rst three years.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> BMC Muscoskel Disord</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2015;16:</span></p>
<p style="top:137.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">27</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:145.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">19.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Evangelopoulos DS, Kohl S, Schwienbacher S, Gantenbein B, Exadaktylos A,</span></p>
<p style="top:153.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Ahmad SS. Collagen application reduces complication rates of mid-substance</span></p>
<p style="top:161.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ACL tears treated with dynamic intraligamentary stabilization.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Knee Surg</span></p>
<p style="top:169.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Sports Traumatol Arthrosc</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2015</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:177.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">20.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Murray MM, Flutie BM, Kalish LA, et al. The bridge-enhanced anterior cruciate</span></p>
<p style="top:185.8pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ligament repair (BEAR) procedure: an early feasibility cohort study.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Orthop J</span></p>
<p style="top:193.7pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Sports Med.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> 2016;4, 2325967116672176</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:201.7pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">21.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Kiapour AM, Fleming BC, Murray MM. Biomechanical outcomes of bridge-</span></p>
<p style="top:209.7pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">enhanced anterior cruciate ligament repair are in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">uenced by sex in a pre-</span></p>
<p style="top:217.7pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">clinical model.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Clin Orthop Relat Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2015;473:2599</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2608</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:225.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">22.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Joshi SM, Mastrangelo AN, Magarian EM, Fleming BC, Murray MM. Collagen-</span></p>
<p style="top:233.6pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">platelet composite enhances biomechanical and histologic healing of the</span></p>
<p style="top:241.6pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">porcine anterior cruciate ligament.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2009;37:2401</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2410</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:249.6pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">23.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Murray MM, Spindler KP, Abreu E, et al. Collagen-platelet rich plasma hydrogel</span></p>
<p style="top:257.5pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">enhances primary repair of the porcine anterior cruciate ligament.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:265.5pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2007;25:81</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">91</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:273.4pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Nguyen DT, Geel J, Schulze M, et al. Healing of the goat anterior cruciate lig-</span></p>
<p style="top:281.4pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ament after a new suture repair technique and bioscaffold treatment.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Tissue</span></p>
<p style="top:289.4pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Eng</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2013;19:2292</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2299</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:297.4pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">25.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Fisher MB, Liang R, Jung HJ, et al. Potential of healing a transected anterior</span></p>
<p style="top:305.4pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cruciate ligament with genetically modi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ed extracellular matrix bioscaffolds in</span></p>
<p style="top:313.3pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">a goat model.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Knee Surg Sports Traumatol Arthrosc</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2012;20:1357</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1365</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:321.3pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">26.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Fleming BC, Magarian EM, Harrison SL, Paller DJ, Murray MM. Collagen scaffold</span></p>
<p style="top:329.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">supplementation does not improve the functional properties of the repaired</span></p>
<p style="top:337.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">anterior cruciate ligament.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2010;28:703</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">709</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:345.2pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">27.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Vavken P, Fleming BC, Mastrangelo AN, Machan JT, Murray MM. Biomechanical</span></p>
<p style="top:353.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">outcomes after bioenhanced anterior cruciate ligament repair and anterior</span></p>
<p style="top:361.1pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cruciate ligament reconstruction are equal in a porcine model.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Arthroscopy</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:369.1pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2012;28:672</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">680</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:377.1pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">28.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Murray MM, Magarian E, Zurakowski D, Fleming BC. Bone-to-bone</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">xation</span></p>
<p style="top:385.0pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">enhances functional healing of the porcine anterior cruciate ligament using a</span></p>
<p style="top:393.0pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">collagen-platelet composite.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Arthroscopy</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2010;26:S49</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">S57</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:401.0pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">29.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Palmer MP, Abreu EL, Mastrangelo A, Murray MM. Injection temperature</span></p>
<p style="top:408.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cantly affects in vitro and in vivo performance of collagen-platelet</span></p>
<p style="top:416.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">scaffolds.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2009;27:964</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">971</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:424.9pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">30.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Mastrangelo AN, Vavken P, Fleming BC, Harrison SL, Murray MM. Reduced</span></p>
<p style="top:432.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">platelet concentration does not harm PRP effectiveness for ACL repair in a</span></p>
<p style="top:440.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">porcine in vivo model.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2011;29:1002</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1007</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:448.8pt;left:32.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">31.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Magarian</span></p>
<p style="top:448.8pt;left:80.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">EM,</span></p>
<p style="top:448.8pt;left:97.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Fleming</span></p>
<p style="top:448.8pt;left:127.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">BC,</span></p>
<p style="top:448.8pt;left:142.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Harrison</span></p>
<p style="top:448.8pt;left:174.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">SL,</span></p>
<p style="top:448.8pt;left:188.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Mastrangelo</span></p>
<p style="top:448.8pt;left:232.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">AN,</span></p>
<p style="top:448.8pt;left:248.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Badger</span></p>
<p style="top:448.8pt;left:275.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">GJ,</span></p>
<p style="top:66.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Murray MM. Delay of 2 or 6 weeks adversely affects the functional outcome of</span></p>
<p style="top:74.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">augmented primary repair of the porcine anterior cruciate ligament.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J</span></p>
<p style="top:82.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2010;38:2528</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2534</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:90.2pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">32.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Magarian EM, Vavken P, Connolly SA, Mastrangelo AN, Murray MM. Safety of</span></p>
<p style="top:98.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">intra-articular use of atelocollagen for enhanced tissue repair.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Open Orthop J</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:106.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2012;6:231</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">238</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:114.1pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">33.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Drogset JO, Grontvedt T, Robak OR, Molster A, Viset AT, Engebretsen L.</span></p>
<p style="top:122.0pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">A sixteen-year follow-up of three operative techniques for the treatment of</span></p>
<p style="top:130.0pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">acute ruptures of the anterior cruciate ligament.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Bone Joint Surg Am.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> 2006;88:</span></p>
<p style="top:137.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">944</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">952</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:145.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">34.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Taylor DC, Posner M, Curl WW, Feagin JA. Isolated tears of the anterior cruciate</span></p>
<p style="top:153.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ligament: over 30-year follow-up of patients treated with arthrotomy and</span></p>
<p style="top:161.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">primary repair.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2009;37:65</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">71</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:169.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">35.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Strand T, Molster A, Hordvik M, Krukhaug Y. Long-term follow-up after pri-</span></p>
<p style="top:177.8pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">mary repair of the anterior cruciate ligament: clinical and radiological evalu-</span></p>
<p style="top:185.8pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ation 15-23 years postoperatively.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Arch Orthop Trauma Surg</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2005;125:</span></p>
<p style="top:193.7pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">217</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">221</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:201.7pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">36.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Webster KE, Feller JA. Exploring the high Reinjury rate in younger patients</span></p>
<p style="top:209.7pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">undergoing anterior cruciate ligament reconstruction.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2016</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:217.7pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">37.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Proffen BL, Sieker JT, Murray MM. Bio-enhanced repair of the anterior cruciate</span></p>
<p style="top:225.6pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">ligament.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Arthroscopy</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2015;31:990</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">997</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:233.6pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">38.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Andersen RB, Gormsen J. Fibrin dissolution in synovial</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt;color:#0a7fac"> &#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">uid.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Scand J Rheumatol</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:241.6pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1987;16:319</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">333</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:249.6pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">39.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Kanzler MH, Gorsulowsky DC, Swanson NA. Basic mechanisms in the healing</span></p>
<p style="top:257.5pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cutaneous wound.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> J Dermatol Surg Oncol</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 1986;12:1156</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1164</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:265.5pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">40.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Murray MM, Spindler KP, Ballard P, Welch TP, Zurakowski D, Nanney LB.</span></p>
<p style="top:273.4pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">Enhanced histologic repair in a central wound in the anterior cruciate ligament</span></p>
<p style="top:281.4pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">with</span></p>
<p style="top:281.4pt;left:334.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">a</span></p>
<p style="top:281.4pt;left:344.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">collagen-platelet-rich</span></p>
<p style="top:281.4pt;left:415.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">plasma</span></p>
<p style="top:281.4pt;left:443.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">scaffold.</span></p>
<p style="top:281.4pt;left:474.0pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">J</span></p>
<p style="top:281.4pt;left:481.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Orthop</span></p>
<p style="top:281.4pt;left:508.2pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Res</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">.</span></p>
<p style="top:281.4pt;left:525.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2007;25:</span></p>
<p style="top:289.4pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1007</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1017</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:297.4pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">41.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Murray MM, Fleming BC. Use of a bioactive scaffold to stimulate anterior</span></p>
<p style="top:305.4pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cruciate ligament healing also minimizes posttraumatic osteoarthritis after</span></p>
<p style="top:313.3pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">surgery.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2013;41:1762</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">1770</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:321.3pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">42.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Gobbi A, Bathan L, Boldrini L. Primary repair combined with bone marrow</span></p>
<p style="top:329.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">stimulation in acute anterior cruciate ligament lesions: results in a group of</span></p>
<p style="top:337.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">athletes.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2009;37:571</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">578</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:345.2pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">43.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Seijas R, Ares O, Cusco X, Alvarez P, Steinbacher G, Cugat R. Partial anterior</span></p>
<p style="top:353.2pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">cruciate ligament tears treated with intraligamentary plasma rich in growth</span></p>
<p style="top:361.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">factors.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> World J Orthoped</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2014;5:373</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">378</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:369.1pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">44.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Hong L, Li X, Zhang H, et al. Anterior cruciate ligament reconstruction with</span></p>
<p style="top:377.1pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">remnant preservation: a prospective, randomized controlled study.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J Sports</span></p>
<p style="top:385.0pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2012;40:2747</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">2755</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:393.0pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">45.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Adachi N, Ochi M, Uchio Y, Sumen Y. Anterior cruciate ligament augmentation</span></p>
<p style="top:401.0pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">under arthroscopy. A minimum 2-year follow-up in 40 patients.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Arch Orthop</span></p>
<p style="top:408.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Trauma Surg</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2000;120:128</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">133</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:416.9pt;left:301.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">46.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac"> Kondo E, Yasuda K, Yamanaka M, Minami A, Tohyama H. Effects of adminis-</span></p>
<p style="top:424.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">tration of exogenous growth factors on biomechanical properties of the</span></p>
<p style="top:432.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">elongation-type anterior cruciate ligament injury with partial laceration.</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac"> Am J</span></p>
<p style="top:440.9pt;left:314.9pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt;color:#0a7fac">Sports Med</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">. 2005;33:188</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt;color:#0a7fac">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#0a7fac">196</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">.</span></p>
<p style="top:47.8pt;left:134.4pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">Y. Li et al. / Asia-Paci</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.4pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">c Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 14 (2018) 10</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">16</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">16</span></p>

</div>
